Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent
1998-04-08
2000-10-24
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
9,10-seco- cyclopentanohydrophenanthrene ring system doai
424236, A61K 3159, A01N 4500
Patent
active
061367990
ABSTRACT:
Stable pharmaceutical formulations of a therapeutic agent, a low molecular weight alcohol and a glycol derivative are disclosed. Preferred formulations include 19-nor-1.alpha.,3.beta.,25-trihydroxy-9,10-secoergosta-5,7(E),22(E)-triene .
REFERENCES:
patent: 4308264 (1981-12-01), Udipi
patent: 4594340 (1986-06-01), Partridge et al.
patent: 4855294 (1989-08-01), Patel et al.
patent: 5098899 (1992-03-01), Gilbert et al.
patent: 5502224 (1996-03-01), Eugster et al.
patent: 5597815 (1997-01-01), Deluca et al.
patent: 5629302 (1997-05-01), Eugster et al.
Bertino et al., Stability of an extemporaneous formulation . . . , American J. of Hosp. Pharmacy, V38(12), p. 1932-1933, 1981.
mortensen et al., Toxicity of 1,25-dihydroxyvitamin D3 . . . , Journal of Investigative Dermat . . . , V 1(1), p. 60-63, 1996.
Whittle et al., Intravenous vitamin D in the detection of . . . , The Lancet, vol. 1, pp. 747-750, (1969).
Bertino et al., Stability of an extra . . . , American J. of Hosp. Pharmacy, vol. 38/12, pp. 1932-1933, (1981).
Jantzi Kathee
Li Lukchiu
May Thomas Barton
Oberdier John Paul
Pec Edward Anthony
Abbott Laboratories
Cintins Marianne M.
Kim Vickie
Steele Gregory W.
LandOfFree
Cosolvent formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cosolvent formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cosolvent formulations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1964183